Zapping away COVID lungs: radiofrequency eases breathlessness
NCT ID NCT07184372
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a special type of radiofrequency (448 kHz) combined with manual techniques to help people with ongoing breathing issues after COVID-19. 96 adults who had COVID and still had cough, shortness of breath, or fatigue for over a month received the treatment. The goal was to see if it could improve lung function and reduce symptoms like dyspnea.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiofrequency (448 kHz) with manual techniques
- What this could lead to
- If it works, this could offer a non-invasive way to help people recover breathing and reduce cough after COVID-19.
- What could go wrong
- This is a small, completed trial with no control group, so results may not be conclusive. The treatment is not a cure and only targets lingering symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COUGH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica de Fisioterapia Gema Leon
Córdoba, Cordoba, 14012, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a simple breathing test unlock the secrets of chronic cough?
- Can a new drug shield lungs from COVID-19's worst damage?